Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06309329Not ApplicableEnrolling By Invitation

Strength at Home - Parents RCT

Role: lead

NCT03529435Not ApplicableCompleted

Project Remission: Maximizing Outcomes With Intensive Treatments for Combat-Related PTSD

Role: collaborator

NCT02957747Not ApplicableCompleted

Addressing the Health Concerns of VA Women With Sexual Trauma

Role: lead

NCT03665740Phase 2Unknown

Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER)

Role: lead

All 4 trials loaded